Archive: 10/07/2017

Disruptive technology for the treatment of hemophilia

An international team of hematologists including Guy Young, MD, of Children's Hospital Los Angeles, has found that in patients with hemophilia A with inhibitors, a novel therapy called emicizumab, decreases incidence of bleeding ...

page 8 from 10